1. Bai Z, Cao Y, Liu W, Li J (2021) The SARS-CoV-2 nucleocapsid protein and its role in viral structure, biological functions, and a poten-tial target for drug or vaccine mitigation. Viruses 13: 1115.
2. Bates TA, Weinstein JB, Farley S, Leier HC, Messer WB, Tafesse FG (2021) Cross-reactivity of SARS-CoV structural protein antibod-ies against SARS-CoV-2. Cell Rep 34: 108737.
3. Chen K, Xiao F, Hu D, Ge W, Tian M, Wang W, Pan P, Wu K, Wu J (2020) SARS-CoV-2 nucleocapsid protein interacts with RIG-I and represses RIG-mediated IFN-β production. Viruses 13: 47.
4. Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92: 418-423.
5. Clementi N, Ghosh S, De Santis M, Castelli M, Criscuolo E, Zanoni I, Clementi M, Mancini N (2021) Viral respiratory pathogens and lung injury. Clin Microbiol Rev 34: e00103-00120.
6. Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, Zhang L, Han L, Dang S, Xu Y, Yang QW, Xu SY, Zhu HD, Xu Y,C Jin Q, Sharma L, Wang L, Wang J (2020) Profiling early humoral response to diagnose novel corona-virus disease (COVID-19). Clin Infect Dis 71: 778-785.
7. Gutiérrez-González M, Farías C, Tello S, Pérez-Etcheverry D, Romero A, Zúñiga R, Ribeiro CH, Lorenzo-Ferreiro C, Molina MC (2019) Optimization of culture conditions for the expression of three different insoluble proteins in Escherichia coli. Sci Rep 9: 16850.
8. Han Y, Luo Z, Zhai W, Zheng Y, Liu H, Wang Y, Wu E, Xiong F, Ma Y (2020) Comparison of the clinical manifestations between dif-ferent age groups of patients with overseas imported COVID-19. PLoS One 15: e0243347.
9. Ji T, Liu Z, Wang G, Guo X, Akbar khan S, Lai C, Chen H, Huang S, Xia S, Chen B, Jia H, Chen Y, Zhou Q (2020) Detection of COVID-19: A review of the current literature and future perspectives. Biosens Bioelectron 166: 112455.
10. Jin Q, Yang J, Lu Q, Guo J, Deng R, Wang Y, Wang S, Wang S, Chen W, Zhi Y, Wang L, Yang S, Zhang G (2012) Development of an immunochromatographic strip for the detection of antibodies against Porcine circovirus-2. J Vet Diagn Invest 24: 1151-1157.
11. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G (2020) Virology, epidemiology, pathogenesis, and control of COVID-19. Vi-ruses 12: 372.
12. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J (2020) The incubation period of coro-navirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 172: 577-582.
13. Leung NH (2021) Transmissibility and transmission of respiratory viruses. Nat Rev Microbiol 19: 528-545.
14. Liao M, Yan J, Wang X, Qian H, Wang C, Xu D, Wang B, Yang B, Liu S, Zhou M, Gao Q, Zhou Q, Luo J, Li Z, Liu W (2020) De-velopment and clinical application of a rapid SARS-CoV-2 antibody test strip: A multi-center assessment across China. J Clin Lab Anal 35: e23619.
15. Liu P, Zong Y, Jiang S, Jiao Y, Yu X (2021) Development of a nucleocapsid protein-based ELISA for detection of human IgM and IgG antibodies to SARS-CoV-2. ACS Omega 6: 9667-9671.
16. Lv Y, Ma Y, Si Y, Zhu X, Zhang L, Feng H, Tian D, Liao Y, Liu T, Lu H, Ling Y (2021) Rapid SARS-CoV-2 antigen detection poten-tiates early diagnosis of COVID-19 disease. Biosci Trends 15: 93-99.
17. Mak GC, Cheng PK, Lau SS, Wong KK, Lau CS, Lam ET, Chan RC, Tsang DN (2020) Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J Clin Virol 129: 104500.
18. Malik YA (2020) Properties of coronavirus and SARS-CoV-2. Malays J Pathol 42: 3-11.
19. Meyer NJ, Gattinoni L, Calfee CS (2021) Acute respiratory distress syndrome. Lancet 398: 622-637.
20. Okba NM, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Hingrat QL, Descamps D, Houhou-Fidouh N, Reusken CB, Bosch BJ, Drosten C, Koopmans MP, Haagmans BL (2020) Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients. Emerg Infect Dis 26: 1478-1488.
21. Rump A, Risti R, Kristal ML, Reut J, Syritski V, Lookene A, Boudinot SR (2021) Dual ELISA using SARS-CoV-2 nucleocapsid pro-tein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation. Biochem Biophys Res Commun 534: 457-460.
22. Singh A, Upadhyay V, Upadhyay AK, Singh SM, Panda AK (2015) Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process. Microb Cell Fact 14: 41.
23. Tian Y, Zhang G, Liu H, Ding P, Jia R, Zhou J, Chen Y, Qi Y, Du J, Liang C, Zhu X, Wang A (2022) Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies. Appl Microbiol Biotechnol 106: 1151-1164.
24. Vashisht K, Goyal B, Pasupureddy R, Na BK, Shin HJ, Sahu D, De S, Chakraborti S, Pandey KC (2023) Exploring the immunodomi-nant epitopes of SARS-CoV-2 nucleocapsid protein as exposure biomarker. Cureus 15: e34827.
25. Wang Y, Liu X, Tao L, Xu P, Gao X, Li H, Yang Z, Wu W (2017) Expression and immunogenicity of VP40 protein of ZEBOV. Arch Iran Med 20: 246-250.
26. Wang YB, Li YH, Li QM, Xie WT, Guo CL, Guo JQ, Deng RG, Zhang GP (2019) Development of a blocking immunoperoxidase monolayer assay for differentiation between pseudorabies virus-infected and vaccinated animals. Pol J Vet Sci 44: 717-723.
27. Zeng W, Liu G, Ma H, Zhao D, Yang Y, Liu M, Mohammed A, Zhao C, Yang Y, Xie J, Ding C, Ma X, Weng J, Gao Y, He H, Jin T (2020) Biochemical characterization of SARS-CoV-2 nucleocapsid protein. Biochem Biophys Res Commun 527: 618-623.
28. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579: 270-273.